A lighting apparatus including a controller including a real time clock, an LED driver, and an LED luminaire including a first light emitting unit including a first LED to emit light having a peak wavelength between 300 to 470 nm and a wavelength converter, and at least one of a second light emitting unit to emit light having a peak wavelength between 286 to 304 nm to cause production of vitamin D, a third light emitting unit to emit light having a peak wavelength between 605 to 935 nm to cause production of a cell activating substance, and a fourth light emitting unit to emit light having a peak wavelength between 400 to 430 nm to sterilize pathogenic microorganisms, in which the controller controls the LED driver to change an irradiance of light emitted from at least one of the light emitting units according to time.

A method of treating a neurological disorder and/or disease includes positioning a stimulation apparatus on a patient. The stimulation apparatus includes an electrode array having a plurality of electrodes and an emitter array having a plurality of emitters. The method further includes measuring electroencephalography (EEG) signals of the patient with the electrode array. The method further includes emitting radiation into the patient's brain from the emitter array based on the measured EEG signals in order to treat the neurological disorder and/or disease.

Systems, devices, apparatuses and methods for an active projection system that may be incorporated into spectacles, contact lenses or provided as an add-on layer to existing spectacles or lenses. The active projection system operates to generate a stimulus or stimuli for viewing by a person's eye. The stimulus or stimuli creates an image that is defocused in front of the person's retina and can assist in slowing or stopping the progression of myopia or other refractive errors in the person.

Systems, devices, apparatuses and methods for an active projection system that may be incorporated into spectacles, contact lenses or provided as an add-on layer to existing spectacles or lenses. The active projection system operates to generate a stimulus or stimuli for viewing by a person’s eye. The stimulus or stimuli creates an image that is defocused in front of the person’s retina and can assist in slowing or stopping the progression of myopia or other refractive errors in the person.

The present specification discloses a photobiomodulation therapy garment having a garment structure configured to be donned by a user atop a skin surface with one or more near-infrared light sources integrated with the garment structure. The near-infrared light source is configured to emit near-infrared light directed to one or more regions of interest of the skin at a wavelength between 600 nm to 1600 nm and at a predetermined dosimetry and duration. A controller with a processor and memory is in communication near-infrared light source to control the operational parameters of the near-infrared light source.

A lighting apparatus including a controller, an LED driver, and an LED luminaire including: a first light emitting unit for general lighting; and at least one of a second light emitting unit to cause production of vitamin D upon irradiation, a third light emitting unit to cause production of a cell activating substance upon irradiation, and a fourth light emitting unit to sterilize pathogenic microorganisms, in which the controller controls the LED driver to change a color temperature of the first light emitting unit in accordance with a change in a color temperature of sunlight, and to change an irradiance of light emitted from at least one of the second, third, and fourth light emitting units according to time, and the LED luminaire includes a greater number of the first light emitting unit than any of the second, third, and fourth light emitting units.

Gamma brain stimulation for preventing or treating Alzheimer's disease or sleeping disorders using light or sound is known. A strobing 40 Hz light source has been shown to cause positive effects due to the stimulation. It is an advantage to know the actual dosage of light that enters the person's eyes in order to understand the relationship between dosage and effectiveness. A camera is used to detect the subject's gaze angle, distance, pupil diameter and any other factors that affect the light power that enters the eye. A target dosage is first determined by a medical worker, such as to determine the effects of the exact same dosage on a group of similar persons, such as Alzheimer's patients. With deviations of gaze angle, distance, and pupil size from the ideal, the effective dosage is decreased. The disclosed system adjusts the actual dosage, such as session duration, based on such factors so that the final dosage received by the person is consistent and meets the target dosage.

Systems and methods for counter-phased binocular stimulation may include a device that determines a target frequency of a stimulation response. The device may output a first visual stimulation at a first frequency and a first phase to a first eye. The device may output a second visual stimulation at a second frequency and a second phase to a second eye. The first visual stimulation and the second visual stimulation may together produce the stimulation response at the target frequency.

A phototherapeutic apparatus for emitting therapeutic light, the apparatus comprising: a first set of one or more light sources and a second set of one or more light sources; a control module configured to control the first and second set of light sources; wherein the control circuit is configured to: control the first set of light sources to generate first light, the first light varying periodically at a first brain stimulation rate; control the second set of light sources to generate second light concurrently with the first set of light sources generating the first light, the second light varying periodically at a second brain stimulation rate equal to the first brain stimulation rate plus a third brain stimulation rate, wherein the third brain stimulation rate is selected for stimulating neural oscillations at a beat frequency corresponding to said third brain stimulation rate

Disorders of the eye can be treated by photobiomodulation therapy according to a device designed to direct light into a patient's eye, no matter the configuration of the eye. The device, including a printed circuit board that includes an array of light delivery devices and a heat sink lens, can be placed proximal to the patient's eye. The light delivery devices can be powered to generate light. The light can be directed into the patient's eye regardless of a position of the patient's eye.